Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment
Author(s) -
Nadiradze ISh,
Chigogidze NSh
Publication year - 2021
Publication title -
global journal of cancer therapy
Language(s) - English
Resource type - Journals
ISSN - 2581-5407
DOI - 10.17352/2581-5407.000038
Subject(s) - metastasis , medicine , chemotherapy , oncology , cancer
The purpose of this work was 1. Processing a new concept of specific inhibitors for metastasis to mercy cancer chemotherapy for oncology. 2. A chemical synthesis of Multinucleated Anion active Metastasis inhibitors based on processed conception. 3. Trial them in D60p4 cell line culture of atypical fibroblasts of different concentrations. Georgia has received a patent for the first medicine (Amphicezine) of this class, which does not damage the normal healthy cells in the body. There are presented the synthesis schemes and methods of prospective metastasis inhibitors by the authors. The second-generation works of Multinucleated Anion active Metastasis inhibitors have been completed, there is also discussed and shown multifunctional action on tumor cells, connections between oncodrugs activity and their ligand properties.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom